Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765570 · ClinicalTrials.gov registry record · Phase 2
Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy
A Phase 2 study, sponsored by Summa Health System.
- Terminated
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00765570 is a Phase 2 study that was terminated before completion, run by Summa Health System. The registered enrollment target is 12 participants.
The verdict
NCT00765570, a Phase 2 study, was terminated before completion, sponsored by Summa Health System.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
Expand clinical literature on the use of Grid radiation with conventional external beam therapy. Vast majority of therapy is for palliative care to provide relief from pain, but has also shown a reduction in the size of tumor mass.
Interventions
- RADIATION Spatially Fractioned Radiation Therapy
- RADIATION Treatment Group 1
- RADIATION Standard radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2003-02 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00765570
The ClinicalTrials.gov registry entry for NCT00765570 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Summa Health System, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Spatially Fractioned Radiation Therapy is the first listed.
NCT00765570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00765570 about?
NCT00765570 is a clinical study titled "Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy". Expand clinical literature on the use of Grid radiation with conventional external beam therapy. Vast majority of therapy is for palliative care to provide relief from pain, but has also shown a reduction in the size of tumor mass.
What is the current status of trial NCT00765570?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2003-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00765570?
The interventions under investigation include: Spatially Fractioned Radiation Therapy (RADIATION), Treatment Group 1 (RADIATION), Standard radiation (RADIATION).
Who is sponsoring clinical trial NCT00765570?
This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.